Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
  1. Home
  2. In The News
  3. Bayer Shares Jump After Monsanto Weedkillers Court Ruling

Bayer Shares Jump After Monsanto Weedkillers Court Ruling

January 4, 2019 in In The News

Wall Street Journal | By Ruth Bender, Donato Paolo Mancini

Bayer AG BAYRY 0.94% shares rose by more than 6% Friday after the German chemicals company scored a court victory in the run-up to jury trials over whether Monsanto Co. weedkillers can cause cancer.

Bayer closed its $63 billion takeover of Monsanto last year, inheriting the St. Louis-based company’s Roundup weedkillers as well as potential legal liabilities.

U.S. District Judge Vince Chhabria granted a request late Thursday from Bayer to stagger the submission of evidence in so-called bellwether trials, potentially limiting the evidence presented by the plaintiff’s lawyers to the jury. Bellwether cases are selected to test arguments and gauge possible recoveries for other similarly situated plaintiffs in an attempt to reach a large-scale resolution.

The judge’s approval for “bifurcation” essentially splits the trial into two phases. Now lawyers for the plaintiff in the first bellwether case must demonstrate that the chemical glyphosate in the weedkillers caused his cancer before they can present evidence that manufacturer Monsanto acted with malice…

Click to read more

May 9, 2019
MDL
SHARE
  • Email
  • Twitter
  • Facebook
  • Google +
  • Pinterest
  • Tumblr
  • Linkedin
  • Vkontakte
  • WhatsApp
Category
  • Filings and Rulings
  • Five-Point Plan
  • In The News
  • Media Statements
  • Resources
    • Documents
    • Infographics
  • Uncategorized
Tags
Ads alesi Benefits carson ferro five-point plan Hardeman Infographics JCCP Johnson MDL Ninth Circuit Pilliod Prop 65 Regulators Roundup Science Settlement Shelton St. Louis City Supreme Court of California

Five-Point Plan to address potential future Roundup™ claims

Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.

Read about the five-point plan here.

Copyright © 2021, All Rights Reserved
Imprint
Privacy Statement

This site was prepared by the Bayer Group for educational purposes only.
For more information on glyphosate herbicides, visit: https://www.bayer.com/en/glyphosate-roundup.aspx.

Copyright © 2019, All Rights Reserved
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
  • Resources
  • Media Center